Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients
- PMID: 16907899
- DOI: 10.1111/j.1365-2036.2006.03019.x
Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients
Abstract
Background: Recent observations in limited numbers of patients suggest a potential benefit of intrapyloric injection of botulinum toxin in the treatment of gastroparesis.
Aim: To characterize the effect of botulinum toxin on solid and liquid gastric emptying and on meal-related symptoms.
Methods: In 20 gastroparesis patients (17 women, mean age 37 +/- 3 years, three diabetic and 17 idiopathic), gastric emptying for solids and liquids was measured before and one month after intrapyloric botulinum toxin 4 x 25 units. Before the meal and at 15-min intervals up to 240 min postprandially, the patient graded the intensity of six gastroparesis symptoms, and a meal-related severity score was obtained by adding all intensities. Data (mean +/- S.E.M.) were compared using paired Student's t-test.
Results: Treatment with botulinum toxin significantly enhanced solid (t(1/2) 132 +/- 16 vs. 204 +/- 35 min, P < 0.05) but not liquid (92 +/- 10 vs. 104 +/- 11 min, N.S.) emptying. This was accompanied by a significant decrease in cumulative meal-related symptom score (73.5 +/- 16.3 vs. 103 +/- 17.1 baseline, P = 0.01) as well as individual severity scores for postprandial fullness, bloating, nausea and belching (all P < 0.001, two-way anova).
Conclusions: Botulinum toxin improves solid but not liquid gastric emptying in gastroparesis, and this is accompanied by significant improvement of several meal-related symptoms.
Similar articles
-
Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.Aliment Pharmacol Ther. 2005 Nov 1;22(9):847-53. doi: 10.1111/j.1365-2036.2005.02658.x. Aliment Pharmacol Ther. 2005. PMID: 16225494 Clinical Trial.
-
Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.Am J Gastroenterol. 2002 Jul;97(7):1653-60. doi: 10.1111/j.1572-0241.2002.05823.x. Am J Gastroenterol. 2002. PMID: 12135014
-
Botulinum toxin A for the treatment of delayed gastric emptying.Am J Gastroenterol. 2008 Feb;103(2):416-23. doi: 10.1111/j.1572-0241.2007.01676.x. Epub 2007 Dec 5. Am J Gastroenterol. 2008. PMID: 18070232 Clinical Trial.
-
Review article: The diagnosis and management of gastroparesis.Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:37-46. doi: 10.1111/j.1365-2036.2007.03534.x. Aliment Pharmacol Ther. 2007. PMID: 18081647 Review.
-
Gastroparesis: approach, diagnostic evaluation, and management.Dis Mon. 2011 Feb;57(2):74-101. doi: 10.1016/j.disamonth.2010.12.007. Dis Mon. 2011. PMID: 21329779 Review.
Cited by
-
Botulinum Toxin Injection for Treatment of Gastroparesis.Gastrointest Endosc Clin N Am. 2019 Jan;29(1):97-106. doi: 10.1016/j.giec.2018.08.007. Epub 2018 Sep 28. Gastrointest Endosc Clin N Am. 2019. PMID: 30396531 Free PMC article. Review.
-
Management of diabetic gastroparesis.Saudi J Gastroenterol. 2011 Mar-Apr;17(2):97-104. doi: 10.4103/1319-3767.77237. Saudi J Gastroenterol. 2011. PMID: 21372345 Free PMC article. Review.
-
Botulinum Toxin A Improves Symptoms of Gastroparesis.Dig Dis Sci. 2020 May;65(5):1396-1404. doi: 10.1007/s10620-019-05885-z. Epub 2019 Oct 15. Dig Dis Sci. 2020. PMID: 31617132 Clinical Trial.
-
Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide.World J Gastroenterol. 2019 Feb 28;25(8):909-922. doi: 10.3748/wjg.v25.i8.909. World J Gastroenterol. 2019. PMID: 30833798 Free PMC article. Review.
-
Targeting the pylorus in gastroparesis: From physiology to endoscopic pyloromyotomy.Neurogastroenterol Motil. 2023 Feb;35(2):e14529. doi: 10.1111/nmo.14529. Epub 2023 Jan 3. Neurogastroenterol Motil. 2023. PMID: 36594414 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous